¹û¶³´«Ã½

Oxford Biomedica profits through collaboration

The deal struck with AstraZeneca is driving the top-line

Mattioli Woods builds discretionary assets as clinical worries ease

The wealth manager has been in an acquisitive mood

PensionBee in expansionary phase

The online pension provider has seen an encouraging rise in assets under management

JTC shows its counter-cyclical side

The professional services business has seen rising new business wins despite wider uncertainties

Clinigen lowers profit growth forecasts

The pharma group has taken steps to simplify its structure, but the possible interest of an activist investors has grabbed the headlines

NCC awaits for the secular growth story to kick in

Trading volumes at the escrow and cyber security group were constrained, as businesses put spending commitments on ice due to repeated disruptions in the economy

AMS recovers as elective surgeries rise

The surgical and woundcare has reported improved volumes as health priorities change

Fevertree surges offshore, but margins falter

An interim sales surge is set against faltering margins

Abcam in-house focus reflected in rising margins

The supplier of protein research tools revealed a sizeable US transaction post period-end

Spire boosted by patients bypassing NHS queues

The private hospital group – and the industry it operates in – have seen mixed fortunes as the pandemic unfolded